Trial
NCT01251354
Study of BN83495 in Post-menopausal Women With Endometrial Cancer Post-chemotherapy
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Ipsen
Collaborators
—
Condition
Endometrial Cancer
Intervention
BN83495
Why stopped
The futility analysis of study NCT00910091 in patients with endometrial cancer shows that the primary endpoint will not be reached.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-01-14